Salkind Gene - Insider Non-Derivative Transactions at Coeptis Therapeutics Holdings, Inc. (COEP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 5, 2024, Salkind Gene's relationship to Coeptis Therapeutics Holdings, Inc. (COEP) is Director, and currently has 284,056 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other COEP insiders.
Data Source: SEC.
Salkind Gene - Insider Non-Derivative Transactions of COEP Common Stock
Salkind Gene - Insider Non-Derivative Transactions at COEP
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 6, 2024 | P -- (Common Stock) | 11600 | 0.69 | 284056 |
| Aug 30, 2023 | P -- (Common Stock) | 4006 | 1.01 | 4046 |
| Aug 26, 2023 | P -- (Common Stock) | 28638 | 0.91 | 28638 |